Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- CheckyesterdayChange Detected- Revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.0%

- Check29 days agoChange DetectedMinor revision bump from v3.4.0 to v3.4.1; no substantive changes to study details or user-facing content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe update adds a 'Show glossary' option and adjusts metadata to 'Last Update Submitted that Met QC Criteria,' updates the 'No FEAR Act Data' label, and changes the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedKyntra Bio has been added as sponsor and FibroGen removed, and the page revision has been updated to v3.3.4.SummaryDifference0.1%

- Check80 days agoChange DetectedThe Locations section has been expanded with many new study sites across the United States, Argentina, Australia, and China, and the revision tag updated to v3.3.3.SummaryDifference3%

Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.